S
Sera Economics
← US Companies

Zoetis Inc.

ZTS · NYSE · CIK 0001555280

SIC 2834

Pharmaceutical Preparations

Category

Chemicals

Entity

operating

Incorp.

-

Fiscal Y/E

1231

Source: SEC EDGAR · All filings on SEC →

Investment Indicators

ROE

80.25%

ROA

17.28%

D/E Ratio

3.64

Current Ratio

3.03

Net Margin

28.23%

Book Value/Share

$7.84

Financial Statements

In USD millions (per-share figures shown directly) · Financials as of: 2026-02-12

Income Statement

FY20252024202320222021
Revenue9,4679,2568,5448,0807,776
Cost of Revenue2,6662,7192,5612,4542,303
Net Income2,6732,4862,3442,1142,037
EPS (Basic)6.035.475.084.514.29
EPS (Diluted)6.025.475.074.494.27

Balance Sheet

FY20252024202320222021
Total Assets15,46714,23714,28614,92513,900
Current Assets6,7685,9866,3437,5066,930
Total Liabilities12,1369,4679,29510,5229,356
Current Liabilities2,2353,4121,8893,1671,797
Long-term Debt9,0425,2206,5646,5526,592
Total Equity3,3314,7704,9974,4054,543

Cash Flow

FY20252024202320222021
Operating CF2,9042,9532,3531,9122,213
Investing CF-748-315-777-883-458
Financing CF-1,870-2,660-3,109-904-1,862
CapEx621655732586477

📄 SEC Filings

Other filings (92)
4

Insider Transaction

FORM 4

2026-05-13

Open →

4

Insider Transaction

FORM 4

2026-05-13

Open →

4

Insider Transaction

FORM 4

2026-05-12

Open →

4

Insider Transaction

FORM 4

2026-05-01

Open →

SCHEDULE 13G

SCHEDULE 13G

xslSCHEDULE_13G_X02/primary_doc.xml

2026-04-30

Open →

SCHEDULE 13G

SCHEDULE 13G

xslSCHEDULE_13G_X02/primary_doc.xml

2026-04-29

Open →

4

Insider Transaction

FORM 4

2026-04-13

Open →

4

Insider Transaction

FORM 4

2026-04-13

Open →

4

Insider Transaction

FORM 4

2026-04-13

Open →

4

Insider Transaction

FORM 4

2026-04-13

Open →

4

Insider Transaction

FORM 4

2026-04-13

Open →

4

Insider Transaction

FORM 4

2026-04-13

Open →

4

Insider Transaction

FORM 4

2026-04-13

Open →

4

Insider Transaction

FORM 4

2026-04-13

Open →

ARS

ARS

ANNUAL REPORT TO SECURITY HOLDERS

2026-04-08

Open →

DEFA14A

DEFA14A

DEFA14A

2026-04-08

Open →

4

Insider Transaction

FORM 4

2026-04-01

Open →

4

Insider Transaction

FORM 4

2026-03-31

Open →

4

Insider Transaction

FORM 4

2026-03-31

Open →

4

Insider Transaction

FORM 4

2026-03-31

Open →

4

Insider Transaction

FORM 4

2026-03-31

Open →

4

Insider Transaction

FORM 4

2026-03-31

Open →

4

Insider Transaction

FORM 4

2026-03-31

Open →

4

Insider Transaction

FORM 4

2026-03-31

Open →

4

Insider Transaction

FORM 4

2026-03-31

Open →

SCHEDULE 13G/A

SCHEDULE 13G/A

xslSCHEDULE_13G_X02/primary_doc.xml

2026-03-27

Open →

4

Insider Transaction

FORM 4

2026-03-20

Open →

4

Insider Transaction

FORM 4

2026-03-10

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-19

Open →

4

Insider Transaction

FORM 4

2026-02-19

Open →

4

Insider Transaction

FORM 4

2026-02-19

Open →

4

Insider Transaction

FORM 4

2026-02-19

Open →

4

Insider Transaction

FORM 4

2026-02-19

Open →

4

Insider Transaction

FORM 4

2026-02-19

Open →

4

Insider Transaction

FORM 4

2026-02-19

Open →

4

Insider Transaction

FORM 4

2026-02-19

Open →

4

Insider Transaction

FORM 4

2026-02-19

Open →

4

Insider Transaction

FORM 4

2026-02-19

Open →

4

Insider Transaction

FORM 4

2026-02-19

Open →

4

Insider Transaction

FORM 4

2026-02-19

Open →

4

Insider Transaction

FORM 4

2026-02-19

Open →

4

Insider Transaction

FORM 4

2026-02-19

Open →

4

Insider Transaction

FORM 4

2026-02-19

Open →

4

Insider Transaction

FORM 4

2026-02-19

Open →

4

Insider Transaction

FORM 4

2026-02-19

Open →

4

Insider Transaction

FORM 4

2026-02-19

Open →

4

Insider Transaction

FORM 4

2026-02-19

Open →

4

Insider Transaction

FORM 4

2026-02-19

Open →

4

Insider Transaction

FORM 4

2026-02-19

Open →

4

Insider Transaction

FORM 4

2026-02-19

Open →

4

Insider Transaction

FORM 4

2026-02-17

Open →

144

144

xsl144X01/primary_doc.xml

2026-02-17

Open →

144

144

xsl144X01/primary_doc.xml

2026-02-17

Open →

144

144

xsl144X01/primary_doc.xml

2026-02-13

Open →

4

Insider Transaction

FORM 4

2026-02-10

Open →

4

Insider Transaction

FORM 4

2026-02-10

Open →

4

Insider Transaction

FORM 4

2026-02-10

Open →

4

Insider Transaction

FORM 4

2026-02-10

Open →

4

Insider Transaction

FORM 4

2026-02-10

Open →

4

Insider Transaction

FORM 4

2026-02-10

Open →

4

Insider Transaction

FORM 4

2026-02-10

Open →

4

Insider Transaction

FORM 4

2026-02-10

Open →

4

Insider Transaction

FORM 4

2026-02-10

Open →

4

Insider Transaction

FORM 4

2026-01-12

Open →

4

Insider Transaction

FORM 4

2026-01-12

Open →

4

Insider Transaction

FORM 4

2026-01-12

Open →

4

Insider Transaction

FORM 4

2026-01-12

Open →

4

Insider Transaction

FORM 4

2026-01-12

Open →

4

Insider Transaction

FORM 4

2026-01-12

Open →

4

Insider Transaction

FORM 4

2026-01-12

Open →

3

3

FORM 3

2026-01-09

Open →

SCHEDULE 13G/A

SCHEDULE 13G/A

xslSCHEDULE_13G_X01/primary_doc.xml

2026-01-07

Open →

Zoetis Inc. (ZTS) — Pharmaceutical Preparations | Sera Economics